Versius Gynecology Study

Recruiting now · Not applicable

Conditions studied: Robotic Assisted Hysterectomy and/or Salpingo-oophorectomy

In brief

The objective of this clinical trial is to expand the clinical evaluation of the safety and efficacy of Versius in gynaecology procedures of total robotic assisted hysterectomy and/or salpingo-oophorectomy

Key facts

Study ID

NCT07289295

Run by

CMR Surgical Ltd

People needed

45

Starts

2025-07-25

Expected to finish

2026-01-01

Last updated by the study team

2025-12-17

Who can join

Age: 22 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female, aged 22 years or above, who provided written informed consent to participate in the study.
• Patient deemed suitable for minimally invasive total hysterectomy and/or Salpingo-Oophorectomy, for benign condition.
• Patient with BMI ≤40.

You may not qualify if…

• Patient unwilling to provide informed consent.
• Medical contraindication for general anaesthesia or minimally invasive procedure.
• Oncological cases, patient undergoing surgery or treatment for malignant disease.
• Clinically assessed Uterus size of > 14 pregnancy weeks (Estimated as > 14-15 cm longitudinal diameter).
• Patient participation in an interventional clinical study that could impact primary outcomes results.
• Patient who falls into American Society of Anaesthesiologists (ASA) Class IV or above (Appendix A).
• Uncontrolled hypertension, uncontrolled diabetes mellitus, or kidney failure.

Where it is running

• Uniwersyteckie Centrum Kliniczne im. prof. K. Gibińskego Śląskiego Uniwersytetu Medycznego w Katowicach — Katowice, Poland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.